BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma

Bradykinin receptor B2 (BDKRB2) has been reported as an oncogene in several malignancies. In glioma, the role of BDKRB2 remains unknown. This study aimed at investigating its clinical significance and biological function in glioma at the transcriptional level. We selected 301 glioma patients with mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Wang, Jin, Shi, Fei, Shan, Aijun, Xu, Shihai, Lv, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993731/
https://www.ncbi.nlm.nih.gov/pubmed/33686021
http://dx.doi.org/10.18632/aging.202614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993731/
https://www.ncbi.nlm.nih.gov/pubmed/33686021
http://dx.doi.org/10.18632/aging.202614

Ejemplares similares